Literature DB >> 16501987

Prehypertension may be common in patients with central serous chorioretinopathy.

Pradeep Venkatesh1, Ritu Gadia, Hem Kumar Tewari, Deepak Kumar, Satpal Garg.   

Abstract

PURPOSE: To test an observational hypothesis that patients with central serous chorioretinopathy (CSCR) may have a tendency towards hypertension compared with normal individuals.
METHODS: In this case-control study we evaluated resting blood pressure in 32 patients with CSCR and compared it with that in 32 healthy controls in a standard laboratory environment. Differences in resting systolic and diastolic blood pressure were measured.
RESULTS: Mean systolic blood pressure was 123.56+/-4.8 in the CSCR group and 113.63+/-12.62 in the control group. Mean diastolic blood pressure was 84.75+/-10.2 in the CSCR group and 76.75+/-0.4 in the control group. The difference in mean blood pressure values between the two groups was statistically significant.
CONCLUSION: Patients with CSCR may be predisposed to prehypertension. Hence they should be advised on lifestyle modification and followed up periodically for early detection of progression to stage 1 or 2 hypertension.

Entities:  

Mesh:

Year:  2006        PMID: 16501987     DOI: 10.1007/s00417-006-0253-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Endocrine abnormalities in patients with central serous chorioretinopathy.

Authors:  Robert Haimovici; Shimon Rumelt; James Melby
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

2.  [Experimental serous choroidopathy (author's transl)].

Authors:  S Watanabe; K Ohtsuki
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1979-07-10

Review 3.  National High Blood Pressure Education Program Working Group report on ambulatory blood pressure monitoring.

Authors: 
Journal:  Arch Intern Med       Date:  1990-11

4.  Systemic findings associated with central serous chorioretinopathy.

Authors:  M K Tittl; R F Spaide; D Wong; E Pilotto; L A Yannuzzi; Y L Fisher; B Freund; D R Guyer; J S Slakter; J A Sorenson
Journal:  Am J Ophthalmol       Date:  1999-07       Impact factor: 5.258

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 6.  Type-A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Retina       Date:  1987       Impact factor: 4.256

7.  Central serous chorioretinopathy and indocyanine green angiography.

Authors:  F C Piccolino; L Borgia
Journal:  Retina       Date:  1994       Impact factor: 4.256

8.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

9.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

10.  Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings.

Authors:  H Yoshioka; Y Katsume; H Akune
Journal:  Ophthalmologica       Date:  1982       Impact factor: 3.250

View more
  3 in total

1.  A new potential risk factor for central serous chorioretinopathy: blood pressure variability.

Authors:  Mehmet Fatih Karadağ
Journal:  Eye (Lond)       Date:  2020-10-19       Impact factor: 4.456

2.  Effect of short-term meditation training in central serous chorioretinopathy.

Authors:  Grisilda Nongrem; Abhidnya Surve; Pradeep Venkatesh; Rajesh Sagar; Raj K Yadav; Rohan Chawla; Rajpal Vohra; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

3.  The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.

Authors:  Yalong Dang; Yalin Mu; Manli Zhao; Lin Li; Yaning Guo; Yu Zhu
Journal:  Ther Clin Risk Manag       Date:  2013-09-02       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.